Sales & Marketing Pharma industry ‘squandering opportunities’ on social media,... A PR company publishes its third report in five years on the evolving use of social media by the pharma industry.
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
